Pelthos Therapeutics(us:PTHS)

16.50

+22.22%

Updated on 2025-07-02

Open:14.85
Close:16.50
High:17.53
Low:13.76
Prev Close:13.50
Volume:27871.00
Turnover:432566.00
Turnover Ratio:4.30%
Shares:648501.00
MarketCap:10.70M

About

Channel Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of therapeutics. It focuses on non-opioid therapy of chronic eye pain. The company was founded in 2002 and is headquartered in Freehold, NJ.
Address:4400 Route 9 South,Suite 1000

Market Movers